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INTRODUCTION:  Multicystic  biliary  hamartoma  is  a rare  liver  tumor  that  was  ﬁrst  described  in  2005.
Only  nine  cases  are  reported  in  the literature  and  all of them  originate  from  Eastern  patient  populations,
speciﬁcally  Japan  and  Korea.
PRESENTATION  OF  CASE:  Herein  we  report  the  occurrence  of the  tenth  multicystic  biliary  hamartoma
reported  to date, arising  in  a Caucasian  American  woman  initially  presenting  with  abdominal  pain.  At
4.7 cm  this  is the second  largest  tumor  reported  to date  and  the only  one  arising  in a Western  patient
population.
DISCUSSION:  The  patient  underwent  multimodality  imaging  and  the tumor  was  biopsied  preoperatively,
but  the  diagnosis  remained  unclear.  An extended  right  hepatectomy  was  performed  for  resection  of her
tumor,  and  the  tumor  was  deﬁnitively  diagnosed  based  on the  surgically  resected  specimen.  As  all  nine
of  the  previously  reported  cases  also underwent  resection,  the  natural  history  of this  lesion  remains
unknown.  The  lack  of both  recurrence  and  tumor  spread  in  the  previously  reported  cases indicates  that
this  may  be a  benign  lesion  not  requiring  surgical  resection  unless  symptomatic.
CONCLUSION:  Multicystic  biliary  hamartoma  is  an extremely  rare  tumor.  Increased  awareness  of  the
radiologic  and  pathologic  features  will  likely  lead  to the  diagnoses  of  further  cases  in both  Western  and
Eastern  populations  and  could  potentially  assist  with  preoperative  diagnosis.  The natural  history  and
optimal  management  of this  tumor  remain  uncertain.
©  2014  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).. Introduction
Multicystic biliary hamartoma (MBH) is a rare liver lesion that
as been described in the last decade as a distinct entity from other
reviously classiﬁed hepatobiliary cystic lesions.1 There are cur-
ently nine cases reported in the literature, with all previous reports
riginating from Japan or Korea (Table 1).1–5 Herein we report a
ase of a MBH  occurring in a Caucasian woman presenting with
bdominal pain. At 4.7 cm it is the second largest lesion reported
n the literature, as well as the only one reported from a Western
opulation to date.
. Presentation of caseIn January 2014, we evaluated a 48-year-old woman for a newly
iagnosed right liver mass. She was symptomatic with epigastric
∗ Corresponding author. Tel.: +1 253 279 7046; fax: +1 617 632 7424.
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210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical A
http://creativecommons.org/licenses/by-nc-nd/3.0/).and right upper quadrant abdominal pain. Her past medical history
was remarkable for recently diagnosed hepatitis C. She had under-
gone an open cholecystectomy 20 years previously for biliary colic
and a hysterectomy 10 years earlier for abnormal uterine bleeding.
She also reported that her paternal aunt had passed away in the
1980s from a very rare liver tumor.
Her workup prior to presentation at our hospital included an
abdominal ultrasound demonstrating an echogenic 5.7 cm mass in
the right lobe of the liver. CT scan showed a 5.6 × 3.4 cm lobulated
subcapsular mass in segment 8 (Fig. 1). Two additional subcentime-
ter cystic lesions, consistent with microhamartomas, were noted
in segment 7 (Fig. 1b). MRI  highlighted its tubulocystic compo-
sition and intermingled normal hepatic tissue (Fig. 2). She had
undergone a needle biopsy of this lesion at an outside hospital
that on microscopic exam demonstrated thick, dense ﬁbrous tissue
containing cytologically bland, large caliber bile ducts with inter-
mingled benign hepatocytes (Fig. 4c). Given the multicystic nature
on imaging and microscopic ﬁndings, this was initially diagnosed
as a possible biliary adenoﬁbroma and the patient was referred
to our institution for surgical evaluation. Complete laboratory
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Table 1
Multicystic biliary hamartomas cases reported to date.
Reference Country of
origin
Cases
reported
Largest tumor
measurement (cm)
Patients’ ages
and genders
Surgical resection
performed
Patient presentation Co-existing
liver disease
Song et al. [2] Korea 1 2.7 52M Not stated Abdominal pain None
Ryu  et al.a [1] Japan 3 2.0–3.5b 45M
58M
55F
Partial resection
Partial resection
Lateral segmentectomy
Incidental ﬁnding on US
for routine checkup
Incidental ﬁnding on US for
routine checkup
Elevated LFTs
None
None
None
Kai  et al. [3] Japan 1 5.0 55M Partial resection of
posterior segment
Finding on US during
workup for Hepatitis B
Hepatitis B
Zen  et al. [4] Japan 3 1.8
2.8
4.2
59M
69F
70F
Left hepatectomy
Resection of medial
segment
Left segmentectomy
Right-sided abdominal
pain
Incidental on imaging
Elevated LFTs
None
HCV cirrhosis
None
Kobayashi et al. [5] Japan 1 3.6 30M Partial hepatectomy Incidental ﬁnding on
imaging
None
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ma Ryu et al. actually reported the imaging ﬁndings of four cases, however one of th
aper,  Zen et al., so only the other three cases are summarized in this table.
b A range of tumor sizes was  provided in this paper but speciﬁc measurements o
tudies including CBC, LFTs, CA19-9, CEA, AFP and hepatitis serolo-
ies were all within normal limits, aside from a HCV antibody that
as positive. HCV RNA and viral load were non-detectable.
Given the possible diagnosis of biliary adenomaﬁbroma and
he potential for malignancy, the patient underwent an extended
ight hepatectomy. Intraoperative ultrasound demonstrated tumor
xtension into segment 4A and involved part of the middle hepatic
ein. During the dissection, note was made of a sizeable replaced
eft hepatic artery and a portal vein that lacked a right common
runk but instead gave direct rise to the right anterior and pos-
erior branches at the bifurcation. The patient recovered without
omplication and was discharged from the hospital the following
eek. She is now eight months post-surgery and has yet to undergo
ny repeat abdominal imaging.
On pathologic examination, the lesion measured
.7 × 4.3 × 4.0 cm and consisted of a subcapsular, intrahepatic,
ell-circumscribed mass with solid and cystic cut surfaces (Fig. 3).
icroscopic exam revealed large bile ducts with varying degrees of
ystic dilation, periductal glands surrounded by ﬁbrous tissue with
nterspersed islands of benign hepatocytes, and bile-like material
bserved within some of the large ducts (Fig 4b and d). These
ig. 1. Axial (a and b), coronal (c) and sagittal (d) contrast-enhanced CT images throug
ular  in segment 8 of the liver. The lesion is predominantly composed of tubulocystic st
icrohamartomas are identiﬁed in segment 7 (b).s, that of the 70-year-old female, had been previously reported in the group’s 2006
 tumor were not.
features were consistent with a diagnosis of MBH.1,4 The back-
ground non-lesional liver demonstrated only mild macrovesicular
steatosis without signiﬁcant ﬁbrosis.
3. Discussion
The diagnosis of MBH  proved challenging, as demonstrated by
the inability to preoperatively diagnose this lesion based on the
radiographic studies and needle biopsies. In a series of four cases
diagnosed by examination of surgically resected specimens from
1998 to 2007, two cases were originally diagnosed as unusual hepa-
tobiliary hamartomas; only after retrospective review, in light of
the original descriptions of the histologic ﬁndings published in
2006, were these diagnoses corrected.1 To our knowledge, our case
is the ﬁrst reported that demonstrates ﬁndings from preoperative
needle core biopsies.The nine previously reported cases in the literature all originated
from Eastern patient populations, but beyond that commonality
the patients’ characteristics and initial clinical presentations var-
ied widely (Table 1). Patients’ ages at time of diagnosis ranged
h the liver demonstrate a 5.6 × 3.4 cm ill-deﬁned lobulated mass located subcap-
ructures intermingled with strands of hepatic parenchyma. Two small additional
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iig. 2. Axial fat-suppressed T2-weighted image (a) through the lesion better demo
elayed post-gadolinium (d) images are included. T1-weighted image (d) demonstr
arenchyma.
rom 30 to 70 years (average 54.8 ± 12.1 years) and six were male.
wo patients presented with abdominal pain; the other tumors
ere discovered incidentally on ultrasound imaging during rou-
ine surveillance or during workup for elevated LFTs. One patient
ad known HCV cirrhosis and one was positive for HBV surface
ntigen; the remaining seven had no known liver disease. Every
ase underwent resection with surgeries ranging from partial seg-
entectomies to lobectomies. Follow-up was reported for six of
he nine cases, with all patients remaining disease free following
esection. Follow-up times ranged from three months to 16 years.
umors were solitary, ranged in size from 1.8 to 5.0 cm and were
ocated in various segments in both liver lobes. Initial descriptions
y Zen et al. summarized the pathology of three cases of MBHs as
haring the following characteristics1: location around the hepatic
apsule near the falciform ligament,2 macroscopic protrusion from
he liver,3 histologic composition consisting of ductal structures,
eriductal glands and ﬁbrous connective tissue,4 bile-like mate-
ial present within ducts and 5 a biliary-type cytokeratin proﬁle
y immunohistochemical studies on the ductal and glandular
ig. 3. Resection, macroscopic image: closeup showing entrapped hepatic
arenchyma intermingled within central and peripheral areas of lesion. Cysts range
n  size from 0.1 to 1.3 cm.es its tubulocystic composition. Pre-gadolinium (b), early post-gadolinium (c), and
e enhancement of the intermingled liver tissue similar to that of surrounding liver
elements within the lesion.4 In subsequent reports, the majority
of lesions occurred in a peripheral location (four cases) but only
one case showed protrusion from the liver.1–3
The radiographic appearance of the lesion in our case is that
of a peripherally located, tubulocystic, honeycomb-like mass in
segment 8, consistent with an aggregate of dilated biliary ducts
and intermingled normal hepatic parenchyma that is best demon-
strated by the MRI  (Fig. 2). Speciﬁc features that distinguish MBH
from other liver masses such as hepatocelluar carcinoma include its
tubulocystic appearance with interspersed normal hepatic tissue,
a honeycomb-like appearance and the more common occurrence
at the periphery rather than centrally.1
Pathologic examination of the surgically resected specimen
revealed characteristic ﬁndings diagnostic of MBH: a circumscribed
lesion with variably dilated cysts comprised of large caliber ducts
and periductal glands within dense ﬁbrous tissue (Fig. 4b and
c), bile-like material within some ducts (Fig. 4d), no protrusion
from the liver surface, and no clear association with the falciform
ligament.4 Some pathologic ﬁndings of the tumor in this case were
distinct from those previously reported, including variably sized
macroscopic and microscopic islands of hepatic parenchyma within
ﬁbrous tissue that were not just at the periphery, but also in the cen-
ter of the lesion. Two  prior cases denote hepatic parenchyma within
ﬁbrous tissue between ducts but radiologic images in those cases
implied that such intermingled hepatic parenchyma only occurred
at the tumor periphery. Of interest, these two  prior cases were
part of a three case series where two  did not protrude from the
liver surface and appeared to be in more peripheral but intrahep-
atic locations.1 Entrapped hepatic parenchyma may  therefore be
more frequently observed in intrahepatic variants of this lesion or,
given that no other reports mentioned the presence of hepatocytes
within this lesion, variations in tumor growth and composition are
also possible.1–5 Many cystically dilated ducts showed attenuated
linings where epithelial cells appeared more cuboidal than colum-
nar; in some ducts, the epithelium appeared ﬂat enough to mimic
mesothelial cells of the liver capsule (Fig. 4a).Diagnosing MBH  on the original needle biopsies proved to be
very difﬁcult due to limited sampling of the lesion and hetero-
geneity in distribution of the tumor components. Since entrapped
hepatic parenchyma was present throughout, this was originally
 –  OPEN  ACCESS
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F s the usual single layer, columnar cell morphology while the right shows an attenuated
a croscopic image: large duct (top), periductal glands (left and right), hepatic parenchyma
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ig. 4. Resection, microscopic image: large duct with cystic dilation; the left show
ppearance with a cuboidal cell morphology, 200× magniﬁcation (a). Resection, mi
center) and intervening dense ﬁbrous tissue, 100× magniﬁcation (b). Biopsy, micros
arge  ducts (center and top right); the periductal glandular component is not seen i
f  large ducts (corners of image, one duct containing bile-like material at upper rig
nd  dense ﬁbrous tissue between the former three components, 40× magniﬁcation
nterpreted as liver parenchyma that was not part of the lesion. Sec-
nd, some cystically dilated ducts showed attenuated epithelium
hat was confused with the peritoneal lining of the liver capsule.
hird, only a rare focus showed the characteristic periductal glan-
ular component. We  infer that these three complicating factors
ere what lead to the interpretation of some of the large ducts sur-
ounded by dense ﬁbrous tissue as non-lesional, large caliber portal
racts, or possibly representing partial sampling of a biliary adenoﬁ-
roma. In retrospect, such dense ﬁbrous tissue and large caliber
ile ducts in a peripheral, subcapsular location would be unusual
or non-lesional liver parenchyma and features typical for biliary
denoﬁbroma, speciﬁcally microcystic, more closely spaced, tubu-
oglandular elements with apocrine snouts separate by thin ﬁbrous
ands, are not seen.6 Given these challenges, a deﬁnitive diagnosis
f MBH  based on the needle core biopsies alone would have been
xtraordinarily difﬁcult.
Early studies with immunohistochemistry demonstrated that
he biliary components of this lesion (periductal glands and large
aliber ducts) are positive for CK7, CK19 and variably positive for
UC1.4 While these markers were helpful in conﬁrming a bil-
ary immunophenotype in the glandular elements of the lesion,
hey are unlikely to be of assistance in clinical practice, as none of
he above immunohistochemical stains can differentiate neoplas-
ic from benign glands or reliably separate MBH  from other entities
n the differential.6 Future studies with novel markers may  yet
eveal a characteristic immunohistochemical phenotype or molec-
lar genotype.
. Conclusion
The diagnosis of MBH  is challenging and requires a keen aware-
ess of this entity. The radiologic and pathologic ﬁndings are
istinctive and additional sampling in this case, potentially by
ntraoperative frozen section, may  have led to an earlier diagnosis.
he lack of recurrence reported in previous cases, along with the
ack of tumor spread or metastasis, suggests that this is a benign
ondition. In this case, given the patient’s symptoms, resectionmage: hepatic parenchyma (left and right) separated dense ﬁbrous tissue containing
 ﬁeld, 40× magniﬁcation (c). Resection, microscopic image: the tumor is composed
riductal glands (best seen at lower right), entrapped hepatic parenchyma (center),
likely would have been performed regardless, however if a similar,
asymptomatic lesion were detected in the future, it may  be reason-
able to simply observe the patient with serial imaging. Given that
all of the reported cases underwent resection shortly after diag-
nosis, the natural history of this tumor’s growth is unknown and
remains a question to be answered.
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Key learning points
• Increased awareness of a rare tumor–multicystic biliary hamartoma.
• Knowledge of diagnostic pitfalls and difﬁculties.
• Questions still remain regarding the natural history and optimal management of this entity.
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